Clinical Trial Update: Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apalutamide before radical prostatectomy in prostate cancer; results were posted on 2025-07-03.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ERLEADA (apalutamide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-07-03